3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
7
Prostatic Neoplasms
6
Brain Neoplasms
6
Neoplasm Metastasis
5
Breast Neoplasms
4
Pancreatic Neoplasms
3
Lung Neoplasms
3
Melanoma
2
Carcinoma, Renal Cell
2
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Cord Neoplasms
1
Spinal Cord Diseases
1
Spinal Cord Compression
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Prostate Cancer Metastatic Disease
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Mouth Neoplasms
1
Lymphatic Metastasis
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Hematologic Neoplasms
1
Gastrointestinal Neoplasms
1
Epidural Neoplasms
1
Interventions
lutetium Lu 177 dotatate
5
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
pembrolizumab
2
olaparib
2
fludarabine
2
cabozantinib
2
X-Rays
2
Phantoms, Imaging
2
Cyclophosphamide
2
tivozanib
1
repotrectinib
1
pazopanib
1
fludarabine phosphate
1
entrectinib
1
belinostat
1
atezolizumab
1
aldesleukin
1
Yttrium-90
1
Tomography, X-Ray Computed
1
Tomography, Emission-Computed, Single-Photon
1
Temozolomide
1
Single Photon Emission Computed Tomography Computed Tomography
1
Salts
1
Positron Emission Tomography Computed Tomography
1
PT-100 dipeptide
1
Octreotide
1
Nivolumab
1
Introns
1
Interferon alpha-2
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroendocrine Tumors
×
Radiosurgery
×
30 days
×
Clear all
No trials found.